Evidence map›Paper›PMID 41063239›Full record

ReviewEpigenetics & chromatin2025

ING5: multifaceted roles beyond tumor suppression in cellular physiology and disease.

Jie Liao, Xiaohuan Zhang, Zhangyuwei Chen, Yingnan Liao

Abstract readReview
In one paragraph

Review in Epigenetics & chromatin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jie LiaoGenetic Diseases Key Laboratory of Sichuan Province, Department of Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Xiaohuan ZhangGenetic Diseases Key Laboratory of Sichuan Province, Department of Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Zhangyuwei ChenGenetic Diseases Key Laboratory of Sichuan Province, Department of Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Yingnan LiaoGenetic Diseases Key Laboratory of Sichuan Province, Department of Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. yingnanliao@foxmail.com.

Funding

National Natural Science Foundation of China 82300342National Natural Science Foundation of China 82300350
6 · The paper itself

Abstract

ING5, initially identified as a tumor-suppressor, serves as a chromatin regulator with a diverse and extensive range of biological functions. This review undertakes an in-depth exploration of the structural characteristics and domain organization of ING family proteins, with a specific emphasis on ING5. The functional characteristics of ING5 are highly intricate and multi-dimensional. In the context of chromatin regulation and gene expression control, ING5 engages in interactions with diverse protein complexes through its conserved domains. It actively participates in the fine-tuning of chromatin structure and gene expression within tumor cells. Moreover, ING5 plays a pivotal and indispensable role in the regulation of DNA replication, cell cycle, and apoptosis, thereby exerting a profound influence on the fundamental biological processes of cells. Additionally, the binding properties and genomic associations of ING5 contribute significantly to its wide-ranging functions. ING5 exerts multiple and intricate action mechanisms in the processes of tumorigenesis, tumor development, and cancer treatment. It has substantial impacts on the biological behaviors of tumor cells, including proliferation, migration, and invasion. Furthermore, ING5 has emerged as a highly promising target for cancer therapy, presenting novel opportunities for the development of tumor-specific treatment strategies. Beyond its well-established role in tumor suppression, ING5 exhibits a diverse array of physiological functions. In the context of stem cell differentiation, ING5 regulates gene expression patterns, which are of utmost importance for determining cell fate. During embryonic development, it ensures the normal expression of genes associated with cell proliferation and differentiation, thereby being essential for the proper morphogenesis of the embryo. ING5 is also involved in metabolic regulation, particularly lipid metabolism, by modulating relevant genes to influence lipid levels. Additionally, it participates in the maintenance of vascular function by regulating the activities of vascular endothelial cells and angiogenesis, which are crucial for vascular homeostasis. This review comprehensively summarizes the extensive functions of ING5 as an epigenetic regulator in maintaining physiological homeostasis. By delving into its roles beyond tumor suppression, we aspire to attain a more comprehensive and in-depth understanding of its significance and potential implications in various biological processes and medical applications.

Indexed as

NeoplasmsTranscription FactorsTumor Suppressor ProteinsAnimalsGene Expression Regulation, NeoplasticHumansING5 protein, humanTranscription FactorsTumor Suppressor ProteinsCardiac developmentDNA replication and cell cycleEpigeneticInhibitor of growth 5Stem cell differentiationTumor suppressor

Identifiers

PMID41063239
PMCPMC12505650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.